These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11731878)

  • 1. Comparison of natural histories of progressive supranuclear palsy and multiple system atrophy.
    Testa D; Monza D; Ferrarini M; Soliveri P; Girotti F; Filippini G
    Neurol Sci; 2001 Jun; 22(3):247-51. PubMed ID: 11731878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early clinical features of patients with progressive supranuclear palsy with predominant cerebellar ataxia.
    Kanazawa M; Tada M; Onodera O; Takahashi H; Nishizawa M; Shimohata T
    Parkinsonism Relat Disord; 2013 Dec; 19(12):1149-51. PubMed ID: 23916652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.
    Litvan I; Mangone CA; McKee A; Verny M; Parsa A; Jellinger K; D'Olhaberriague L; Chaudhuri KR; Pearce RK
    J Neurol Neurosurg Psychiatry; 1996 Jun; 60(6):615-20. PubMed ID: 8648326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of survival in progressive supranuclear palsy and multiple system atrophy: a systematic review and meta-analysis.
    Glasmacher SA; Leigh PN; Saha RA
    J Neurol Neurosurg Psychiatry; 2017 May; 88(5):402-411. PubMed ID: 28250027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes of progressive supranuclear palsy and multiple system atrophy.
    O'Sullivan SS; Massey LA; Williams DR; Silveira-Moriyama L; Kempster PA; Holton JL; Revesz T; Lees AJ
    Brain; 2008 May; 131(Pt 5):1362-72. PubMed ID: 18385183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes of two main variants of progressive supranuclear palsy and multiple system atrophy: a prospective natural history study.
    Jecmenica-Lukic M; Petrovic IN; Pekmezovic T; Kostic VS
    J Neurol; 2014 Aug; 261(8):1575-83. PubMed ID: 24888315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease.
    Fiorenzato E; Antonini A; Camparini V; Weis L; Semenza C; Biundo R
    J Neural Transm (Vienna); 2019 Nov; 126(11):1437-1445. PubMed ID: 31432258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990.
    Bower JH; Maraganore DM; McDonnell SK; Rocca WA
    Neurology; 1997 Nov; 49(5):1284-8. PubMed ID: 9371909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive Supranuclear Palsy, Corticobasal Degeneration, and Multiple System Atrophy.
    Greene P
    Continuum (Minneap Minn); 2019 Aug; 25(4):919-935. PubMed ID: 31356287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurogenic bladder in progressive supranuclear palsy: A comparison with Parkinson's disease and multiple system atrophy.
    Kim KJ; Jeong SJ; Kim JM
    Neurourol Urodyn; 2018 Jun; 37(5):1724-1730. PubMed ID: 29356135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study.
    Bensimon G; Ludolph A; Agid Y; Vidailhet M; Payan C; Leigh PN;
    Brain; 2009 Jan; 132(Pt 1):156-71. PubMed ID: 19029129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Joint and skeletal deformities in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
    Ashour R; Jankovic J
    Mov Disord; 2006 Nov; 21(11):1856-63. PubMed ID: 16941460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].
    Yoshita M; Hayashi M; Hirai S
    Rinsho Shinkeigaku; 1997 Jun; 37(6):476-82. PubMed ID: 9366173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy.
    Fiorenzato E; Weis L; Falup-Pecurariu C; Diaconu S; Siri C; Reali E; Pezzoli G; Bisiacchi P; Antonini A; Biundo R
    J Neural Transm (Vienna); 2016 Dec; 123(12):1435-1442. PubMed ID: 27334897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving diagnostic accuracy of multiple system atrophy: a clinicopathological study.
    Miki Y; Foti SC; Asi YT; Tsushima E; Quinn N; Ling H; Holton JL
    Brain; 2019 Sep; 142(9):2813-2827. PubMed ID: 31289815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study.
    Litvan I; Campbell G; Mangone CA; Verny M; McKee A; Chaudhuri KR; Jellinger K; Pearce RK; D'Olhaberriague L
    Brain; 1997 Jan; 120 ( Pt 1)():65-74. PubMed ID: 9055798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurements of transcallosally mediated cortical inhibition for differentiating parkinsonian syndromes.
    Wolters A; Classen J; Kunesch E; Grossmann A; Benecke R
    Mov Disord; 2004 May; 19(5):518-28. PubMed ID: 15133815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiological and clinical assessment of dysautonomia in multiple system atrophy (MSA) and progressive supranuclear palsy (PSP): a comparative study.
    Nojszewska M; Potulska-Chromik A; Jamrozik Z; Janik P; Zakrzewska-Pniewska B
    Neurol Neurochir Pol; 2019; 53(1):26-33. PubMed ID: 30620042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obsessive compulsive personality disorder in Progressive Supranuclear Palsy, Multiple System Atrophy and Essential Tremor.
    Nicoletti A; Luca A; Luca M; Donzuso G; Mostile G; Raciti L; Contrafatto D; Dibilio V; Sciacca G; Cicero CE; Vasta R; Petralia A; Zappia M
    Parkinsonism Relat Disord; 2016 Sep; 30():36-9. PubMed ID: 27364040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary Dysfunction in Progressive Supranuclear Palsy Compared with Other Parkinsonian Disorders.
    Yamamoto T; Tateno F; Sakakibara R; Furukawa S; Asahina M; Uchiyama T; Hirano S; Yamanaka Y; Fuse M; Koga Y; Yanagisawa M; Kuwabara S
    PLoS One; 2016; 11(2):e0149278. PubMed ID: 26886104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.